![Raj Pruthi MD, MHA, FACS](https://res.cloudinary.com/els-assets/image/upload/c_fill_pad,f_auto,g_auto,h_150,q_auto,w_120/v1/practice-update/remote-media/contentimage/22484.jpg)
Raj S Pruthi MD, MHA, FACS
Rhodes Distinguished Professor and Chair Department of Urology, University of North Carolina School of Medicine Chapel Hill, North CarolinaRaj S. Pruthi, MD, MHA, is the Rhodes Distinguished Professor and Chair of the Department of Urology at the University of North Carolina at Chapel Hill. He also serves as disease group leader for the Genitourinary Oncology program at the NIH- sponsored Lineberger Comprehensive Cancer Center at UNC.
He is a graduate of Stanford University and received his MD degree from Duke University School of Medicine. Following medical school, he completed his residency and post-graduate training at Stanford University. Most recently, he completed the executive MHA program at UNC
Dr. Pruthi currently serves on a number of institutional, regional, and national teaching and professional capacities, and is currently a member of the American Urological Associations Guidelines on the Management of Non-muscle Invasive Bladder Cancer, the Bladder Cancer Guidelines Committee of the International Consultation on Urological Diseases, the ABU/AUA Examination Committee, the American College of Surgeons Advisory Council and Chair of the Program Committee for Urology, Treasurer for the Society of Academic Urology, a Governor and member of the Board of Regents for the American College of Surgeons, Board of Directors for the Southeastern Section of the American Urological Association, the Society of Pelvic surgeons, and the American Association of Genitourinary Surgeons. He is also on the Executive Committee for the UNC Faculty Practice and on the Board of the UNC Healthcare Alliance and Senior alliance, a clinically-integrated network and Medicare ACO, respectively.
His clinical and research interests are in urologic oncology including bladder, kidney, and prostate cancer, and has published over 200 peer review publications in these areas. In addition to serving as a consultant and reviewer for numerous publications, he has also served on the editorial board for several journals including the Journal of Urology, British Journal of Urology, World Journal of Urology, Prostate Cancer and Prostatic Diseases, amongst others.